199 related articles for article (PubMed ID: 22303826)
1. US FDA/EMA harmonization of their bioanalytical guidance/guideline and activities of the Global Bioanalytical Consortium.
Garofolo F; Michon J; Leclaire V; Booth B; Lowes S; Viswanathan CT; Welink J; Haidar S; Teixeira Lde S; Tang D; Desilva B
Bioanalysis; 2012 Feb; 4(3):231-6. PubMed ID: 22303826
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry.
Kadian N; Raju KS; Rashid M; Malik MY; Taneja I; Wahajuddin M
J Pharm Biomed Anal; 2016 Jul; 126():83-97. PubMed ID: 27179186
[TBL] [Abstract][Full Text] [Related]
3. Capsule review on bioanalytical method transfer: opportunities and challenges for chromatographic methods.
Lin ZJ; Li W; Weng N
Bioanalysis; 2011 Jan; 3(1):57-66. PubMed ID: 21175367
[TBL] [Abstract][Full Text] [Related]
4. The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation.
van Amsterdam P; Companjen A; Brudny-Kloeppel M; Golob M; Luedtke S; Timmerman P
Bioanalysis; 2013 Mar; 5(6):645-59. PubMed ID: 23484783
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on updates, clarifications and controversies in chromatographic assay guidance for bioanalytical method validation from major regulatory agencies and organizations.
King K; Li P; Pietrasiewicz A; Goldstein S
Biomed Chromatogr; 2021 Jan; 35(1):e5030. PubMed ID: 33201529
[TBL] [Abstract][Full Text] [Related]
6. Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?
Kaza M; Karaźniewicz-Łada M; Kosicka K; Siemiątkowska A; Rudzki PJ
J Pharm Biomed Anal; 2019 Feb; 165():381-385. PubMed ID: 30590335
[TBL] [Abstract][Full Text] [Related]
7. Conference report: Discussion on harmonization and globalization of bioanalytical guidances at the 19th International Reid Bioanalytical Forum.
Garofolo F; Smeraglia J; Briggs R; Seymour M; Hill H
Bioanalysis; 2011 Dec; 3(24):2717-20. PubMed ID: 22185270
[TBL] [Abstract][Full Text] [Related]
8. Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC).
Boterman M; Doig M; Breda M; Lowes S; Jersey J; Shoup R; Garofolo F; Dumont I; Martinez S; Needham S; Cruz Caturla M; Couerbe P; Guittard J; Maltas J; Lansing T; Bhatti M; Schiebl C; Struwe P; Sheldon C; Hayes R; Sangster T; Pattison C; Bouchard J; Goodwin L; Islam R; Segers R; Lin ZJ; Hillier J; Garofolo W; Zimmer D; Folguera L; Zimmermann T; Pawula M; Moussallie M; Teixeira Lde S; Rocha T; Tang D; Jardieu P; Truog J; Lin J; Lundberg R; Cox C; Breau A; Bigogno C; Schoutsen D; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Nicholson R; Jenkins R; Lin MH; Karnik S; De Boer T; Houghton R; Green R; DeMaio W; Sable R; Smith K; Siethoff C; Cojocaru L; Allen M; Harter T; Fatmi S; Sayyarpour F; Malone M; Best S; Fang X
Bioanalysis; 2012 Mar; 4(6):651-60. PubMed ID: 22452256
[No Abstract] [Full Text] [Related]
9. 2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists.
Sudsakorn S; Bahadduri P; Fretland J; Lu C
Curr Drug Metab; 2020; 21(6):403-426. PubMed ID: 32562522
[TBL] [Abstract][Full Text] [Related]
10. 8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validation.
Bower J; Fast D; Garofolo F; Gouty D; Hayes R; Lowes S; Nicholson R; LeLacheur R; Bravo J; Shoup R; Dumont I; Carbone M; Zimmer J; Ortuno J; Caturla MC; Datin J; Lansing T; Fatmi S; Struwe P; Sheldon C; Islam R; Yu M; Hulse J; Kamerud J; Lin J; Doughty J; Kurylak K; Tang D; Buonarati M; Blanchette A; Levesque A; Gagnon-Carignan S; Lin J; Ray G; Liu Y; Khan M; Xu A; El-Sulayman G; DiMarco C; Bouhajib M; Tacey D; Jenkins R; der Strate Bv; Briscoe C; Karnik S; Rhyne P; Garofolo W; Schultz G; Roberts A; Redrup M; DuBey I; Conliffe P; Pekol T; Hantash J; Cojocaru L; Allen M; Reuschel S; Watson A; Farrell C; Groeber E; Malone M; Nowatzke W; Fang X
Bioanalysis; 2014; 6(22):2957-63. PubMed ID: 25496252
[TBL] [Abstract][Full Text] [Related]
11. Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference.
Yu LX; Baker J; Berlam SC; Boam A; Brandreth EJ; Buhse L; Cosgrove T; Doleski D; Ensor L; Famulare J; Ganapathy M; Grampp G; Hussong D; Iser R; Johnston G; Kesisoglou F; Khan M; Kozlowski S; Lacana E; Lee SL; Miller S; Miksinski SP; Moore CM; Mullin T; Raju GK; Raw A; Rosencrance S; Rosolowsky M; Stinavage P; Thomas H; Wesdyk R; Windisch J; Vaithiyalingam S
AAPS J; 2015 Jul; 17(4):1011-8. PubMed ID: 25840884
[TBL] [Abstract][Full Text] [Related]
12. EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations.
Boesen K; Gøtzsche PC; Ioannidis JPA
Epidemiol Psychiatr Sci; 2021 Apr; 30():e35. PubMed ID: 33926608
[TBL] [Abstract][Full Text] [Related]
13. Conference report: AAPS and US FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation: feedback from the EBF.
Smeraglia J; McDougall S; Elsby K; Companjen A; White S; Golob M; Brudny-Kloeppel M; Amsterdam Pv; Timmerman P
Bioanalysis; 2014 Mar; 6(6):729-32. PubMed ID: 24702107
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
Reinisch W; Gottlieb K; Colombel JF; Danese S; Panaccione R; Panes J; Peyrin-Biroulet L; Rubin D; Sands BE; Schreiber S; Vermeire S; Mulberg A; Sandborn B
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1673-1679.e1. PubMed ID: 31352970
[TBL] [Abstract][Full Text] [Related]
15. Guidelines and strategy of the International Conference of Harmonization (ICH) and its member states to overcome existing impurity control problems for antibiotics in China.
Jiang Y; Xia JP; Yang JH; Zhang ZF; Hu CQ; Zhang ZR
Chin J Nat Med; 2015 Jul; 13(7):498-506. PubMed ID: 26233840
[TBL] [Abstract][Full Text] [Related]
16. 4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryover.
Lowes S; Jersey J; Shoup R; Garofolo F; Needham S; Couerbe P; Lansing T; Bhatti M; Sheldon C; Hayes R; Islam R; Lin Z; Garofolo W; Moussallie M; Teixeira Lde S; Rocha T; Jardieu P; Truog J; Lin J; Lundberg R; Breau A; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Jenkins R; Nicholson R; Lin MH; Karnik S; DeMaio W; Smith K; Cojocaru L; Allen M; Fatmi S; Sayyarpour F; Malone M; Fang X
Bioanalysis; 2012 Apr; 4(7):763-8. PubMed ID: 22512795
[TBL] [Abstract][Full Text] [Related]
17. Tiered approaches to chromatographic bioanalytical method performance evaluation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium harmonization team.
Lowes S; Hucker R; Jemal M; Marini JC; Rezende VM; Shoup R; Singhal P; Timmerman P; Yoneyama T; Weng N; Zimmer D
AAPS J; 2015 Jan; 17(1):17-23. PubMed ID: 25338740
[TBL] [Abstract][Full Text] [Related]
18. Implications of differences in bioanalytical regulations between Canada, USA and South America.
Arnold ME
Bioanalysis; 2011 Feb; 3(3):253-8. PubMed ID: 21320043
[TBL] [Abstract][Full Text] [Related]
19. Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management.
Huang Y; Shi R; Gee W; Bonderud R
Bioanalysis; 2012 Aug; 4(15):1919-31. PubMed ID: 22943622
[TBL] [Abstract][Full Text] [Related]
20. Bioanalytical method validation: notable points in the 2009 draft EMA Guideline and differences with the 2001 FDA Guidance.
Smith G
Bioanalysis; 2010 May; 2(5):929-35. PubMed ID: 21083222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
